Offering optimized workflow and dataflow for high-volume, time-constrained clinical environments, Apollo™ v2.0 identifies objective information to better understand disease subtypes, to interact with results at point of procedure, and to aid in identifying optimal treatment strategies for patients with lung disease. FDA-cleared, CE, CMDCAS, and TGA certified, program enables distributed review of results and provides optimized structured reporting.
This story is related to the following:Imaging Software |